SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-188624
Filing Date
2009-09-08
Accepted
2009-09-08 17:01:01
Documents
4
Period of Report
2009-09-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15548
2 PRESS RELEASE dex991.htm EX-99.1 9313
3 GRAPHIC g93388g29j21.jpg GRAPHIC 4834
4 GRAPHIC g93388g62b19.jpg GRAPHIC 3163
  Complete submission text file 0001193125-09-188624.txt   37723
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 091058604
SIC: 2834 Pharmaceutical Preparations